Literature DB >> 27769355

Structural features and inhibitors of bromodomains.

Jamel Meslamani1, Steven G Smith2, Roberto Sanchez2, Ming-Ming Zhou2.   

Abstract

Bromodomains are conserved structural modules responsible for recognizing acetylated-lysine residues on histone tails and other transcription-associated proteins, such as transcription factors and co-factors. Owing to their important functions in the regulation of ordered gene transcription in chromatin, bromodomains of the BET family proteins have recently been shown as druggable targets for a wide array of human diseases, including cancer and inflammation. Here we review the structural and functional features of the bromodomains and their small-molecule inhibitors. Additional new insights provided herein highlight the landscape of the ligand binding sites in the bromodomains that will hopefully facilitate further development of new inhibitors with optimal affinity and selectivity.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27769355      PMCID: PMC5325140          DOI: 10.1016/j.ddtec.2016.09.001

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  64 in total

Review 1.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 2.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

Review 3.  Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence.

Authors:  Aristeidis Chaidos; Valentina Caputo; Anastasios Karadimitris
Journal:  Ther Adv Hematol       Date:  2015-06

4.  Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.

Authors:  Lele Zhao; Danyan Cao; Tiantian Chen; Yingqing Wang; Zehong Miao; Yechun Xu; Wuyan Chen; Xin Wang; Yanlian Li; Zhiyan Du; Bing Xiong; Jian Li; Chunyan Xu; Naixia Zhang; Jianhua He; Jingkang Shen
Journal:  J Med Chem       Date:  2013-05-14       Impact factor: 7.446

5.  Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.

Authors:  Terry D Crawford; Vickie Tsui; E Megan Flynn; Shumei Wang; Alexander M Taylor; Alexandre Côté; James E Audia; Maureen H Beresini; Daniel J Burdick; Richard Cummings; Les A Dakin; Martin Duplessis; Andrew C Good; Michael C Hewitt; Hon-Ren Huang; Hariharan Jayaram; James R Kiefer; Ying Jiang; Jeremy Murray; Christopher G Nasveschuk; Eneida Pardo; Florence Poy; F Anthony Romero; Yong Tang; Jian Wang; Zhaowu Xu; Laura E Zawadzke; Xiaoyu Zhu; Brian K Albrecht; Steven R Magnuson; Steve Bellon; Andrea G Cochran
Journal:  J Med Chem       Date:  2016-05-31       Impact factor: 7.446

6.  Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.

Authors:  Lewis R Vidler; Nathan Brown; Stefan Knapp; Swen Hoelder
Journal:  J Med Chem       Date:  2012-07-12       Impact factor: 7.446

7.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

8.  LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Authors:  Peter G K Clark; Lucas C C Vieira; Cynthia Tallant; Oleg Fedorov; Dean C Singleton; Catherine M Rogers; Octovia P Monteiro; James M Bennett; Roberta Baronio; Susanne Müller; Danette L Daniels; Jacqui Méndez; Stefan Knapp; Paul E Brennan; Darren J Dixon
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-13       Impact factor: 15.336

9.  BRD4 inhibitor inhibits colorectal cancer growth and metastasis.

Authors:  Yuan Hu; Jieqiong Zhou; Fei Ye; Huabao Xiong; Liang Peng; Zihan Zheng; Feihong Xu; Miao Cui; Chengguo Wei; Xinying Wang; Zhongqiu Wang; Hongfa Zhu; Peng Lee; Mingming Zhou; Bo Jiang; David Y Zhang
Journal:  Int J Mol Sci       Date:  2015-01-16       Impact factor: 5.923

10.  GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain.

Authors:  Paul Bamborough; Heather A Barnett; Isabelle Becher; Mark J Bird; Chun-Wa Chung; Peter D Craggs; Emmanuel H Demont; Hawa Diallo; David J Fallon; Laurie J Gordon; Paola Grandi; Clare I Hobbs; Edward Hooper-Greenhill; Emma J Jones; Robert P Law; Armelle Le Gall; David Lugo; Anne-Marie Michon; Darren J Mitchell; Rab K Prinjha; Robert J Sheppard; Allan J B Watson; Robert J Watson
Journal:  ACS Med Chem Lett       Date:  2016-05-09       Impact factor: 4.345

View more
  6 in total

1.  Vitamin C Sensitizes Melanoma to BET Inhibitors.

Authors:  Sushmita Mustafi; Vladimir Camarena; Claude-Henry Volmar; Tyler C Huff; David W Sant; Shaun P Brothers; Zhao-Jun Liu; Claes Wahlestedt; Gaofeng Wang
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

Review 2.  BET proteins: Investigating BRDT as a potential target for male contraception.

Authors:  Andrea Wisniewski; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2020-01-21       Impact factor: 2.823

Review 3.  Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives.

Authors:  Mohammed Ghiboub; Ahmed M I Elfiky; Menno P J de Winther; Nicola R Harker; David F Tough; Wouter J de Jonge
Journal:  J Pers Med       Date:  2021-04-23

Review 4.  The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.

Authors:  Ekaterina Bourova-Flin; Florent Chuffart; Sophie Rousseaux; Saadi Khochbin
Journal:  Cell J       Date:  2017-05-17       Impact factor: 2.479

5.  SMMPPI: a machine learning-based approach for prediction of modulators of protein-protein interactions and its application for identification of novel inhibitors for RBD:hACE2 interactions in SARS-CoV-2.

Authors:  Priya Gupta; Debasisa Mohanty
Journal:  Brief Bioinform       Date:  2021-04-12       Impact factor: 11.622

6.  Acetylation of H3K4, H3K9, and H3K27 mediated by p300 regulates the expression of GATA4 in cardiocytes.

Authors:  Wei Zhou; Dagui Jiang; Jie Tian; Lingjuan Liu; Tiewei Lu; Xupei Huang; Huichao Sun
Journal:  Genes Dis       Date:  2018-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.